Craig Woods, DVM, MS, MBA



  • DVM – 1995 – University of Missouri
  • MS – 1995 – University of Missouri
  • MBA – 2003 – Arizona State University
  • BS – 1991 – University of Missouri

RESEARCH Interests

  • Toxinology: antivenoms, antitoxins, venom pathophysiology
  • Regenerative Medicine: biological scaffolds, cell based therapeutics
  • Immunotherapeutics: immune modulatory peptides
  • Pharmaco-economics: financial analysis of drug development


  • Phase II-IV human clinical trials
  • Comparative and translational veterinary trials

As Director of the IHI, Dr. Woods uses his 15+ years of clinical research and industry experience to advance therapeutics and diagnostics for veterinary and human medicine.  His approach to clinical research takes into account the potential clinical benefit, plus other factors such as the regulatory pathway, financial feasibility, and various other factors affecting the drug development process. Dr. Woods overall goal is to see clinical research projects translate into patient availability.

From 1995 until 1998, Dr. Woods was in small animal practice. In 1998, he entered industry where he held various senior level positions for pharmaceutical companies located in the US, Mexico, and France. Dr. Woods has a background in clinical trials, project management, regulatory affairs, due diligence, and business development, and has led numerous technology licensing transactions for life science companies.  As a clinical research scientist, he has conducted clinical trials in ophthalmology, envenomation, regenerative medicine, infectious disease, and immune mediated conditions.  Dr. Woods has presented original research at various medical conferences, and published in the Journal of Rheumatology, Journal of Veterinary Emergency and Critical Care, and Toxicon. Craig has been a licensed veterinarian in Arizona since 1995.